This website uses cookies.
By continuing to use this website, you consent to our use of these cookies. Read more about our use of cookies
Elocta® is the first extended half-life recombinant factor VIII approved in the EU
You are about to enter elocta.com.
Please select if you are a healthcare professional or a patient.
I'm a